These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37328622)

  • 1. [
    Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of [
    Qiao K; Qin X; Fu S; Ren J; Jia J; Hu X; Tao Y; Yuan S; Wei Y
    Eur Radiol; 2024 Mar; 34(3):1948-1959. PubMed ID: 37670186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical FAP Expression Reflects
    Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
    J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of Al
    Lyu Z; Han W; Zhang Q; Zhao H; Liu S; Wang Y; He J; Zhao C; Tian L; Fu P
    Cancer Imaging; 2023 Sep; 23(1):86. PubMed ID: 37700343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive performance of [
    Wu C; Wen F; Lin F; Zeng Y; Lin X; Hu X; Zhang X; Zhang X; Wang X
    Quant Imaging Med Surg; 2024 Aug; 14(8):5333-5345. PubMed ID: 39144061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
    Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
    Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Wang H; Zhang P; Wang W; He L; Liu N; Yang J; Tang D; Li G; Feng Y; Zhang W
    Clin Kidney J; 2024 May; 17(5):sfae064. PubMed ID: 38803395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Guberina N; Kessler L; Pöttgen C; Guberina M; Metzenmacher M; Herrmann K; Mucha M; Rischpler C; Indenkämpen F; Siveke JT; Treckmann J; Umutlu L; Kasper S; Fendler WP; Stuschke M
    Sci Rep; 2022 Sep; 12(1):16261. PubMed ID: 36171444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhao Y; Ren J
    Front Immunol; 2023; 14():1266843. PubMed ID: 38035081
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
    J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
    Karbhari A; Mosessian S; Trivedi KH; Valla F; Jacobson M; Truty MJ; Patnam NG; Simeone DM; Zan E; Brennan T; Chen H; Kuo PH; Herrmann K; Goenka AH
    PLoS One; 2023; 18(11):e0294564. PubMed ID: 38011131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of [
    Rao W; Fang XH; Zhao Y; Wang Y; Zhang B; Wei Z; Kong X; Cai JZ; Yang G; Xie M
    Jpn J Radiol; 2024 May; 42(5):536-545. PubMed ID: 38316724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.